Skip to main content

Flammer Martina M.D.'s Form 4 filing

INSMED Inc (INSM) · filed Sep 10, 2024

Accession no.
0001628280-24-040022
Filed
Sep 10, 2024
Trade date
Sep 6, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 9 non-derivative transactions and 6 derivative transactions. Open-market sales total $10.6M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Flammer Martina M.D.CIK 0001796960Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 6, 2024Common StockMOption exerciseAcquired+36,555$18.95+$692,717.25142,689Direct
Sep 6, 2024Common StockMOption exerciseAcquired+25,740$26.46+$681,080.4168,429Direct
Sep 6, 2024Common StockMOption exerciseAcquired+18,874$23.66+$446,558.84187,303Direct
Sep 6, 2024Common StockMOption exerciseAcquired+34,280$26.43+$906,020.4221,583Direct
Sep 6, 2024Common StockMOption exerciseAcquired+14,130$23.75+$335,587.5235,713Direct
Sep 6, 2024Common StockMOption exerciseAcquired+19,423$17.07+$331,550.61255,136Direct
Sep 6, 2024Common StockSSaleDisposed−76,455$70.90F2−$5,420,659.5178,681Direct
Sep 6, 2024Common StockSSaleDisposed−63,483$71.43F3−$4,534,590.69115,198Direct
Sep 6, 2024Common StockSSaleDisposed−9,064$72.61F4−$658,137.04106,134Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 6, 2024Common StockMOption exerciseDisposed−36,555$0.00$0109,665Direct
Sep 6, 2024Common StockMOption exerciseDisposed−25,740$0.00$042,900Direct
Sep 6, 2024Common StockMOption exerciseDisposed−18,874$0.00$00Direct
Sep 6, 2024Common StockMOption exerciseDisposed−34,280$0.00$034,280Direct
Sep 6, 2024Common StockMOption exerciseDisposed−14,130$0.00$00Direct
Sep 6, 2024Common StockMOption exerciseDisposed−19,423$0.00$084,167Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This is the weighted average sales price representing 76,455 shares sold at prices ranging from $70.20 to $71.20 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F3

This is the weighted average sales price representing 63,483 shares sold at prices ranging from $71.21 to $72.19 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F4

This is the weighted average sales price representing 9,064 shares sold at prices ranging from $72.23 to $73.07 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)